Girard Partners’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$5.7M Buy
2024
Q1
$7.45M Buy
2023
Q4
$5.89M Buy
2023
Q3
$4.26M Buy
2023
Q2
$4.35M Buy